Gentler IVF alternative tested for PCOS patients
NCT ID NCT07274202
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares in vitro maturation (IVM) to conventional ovarian stimulation in 84 women with severe PCOS undergoing their first fertility treatment. The goal is to see which method causes less pain, fewer side effects, and better quality of life. Participants will fill out questionnaires at several points during treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- In vitro maturation (IVM) of oocytes
- What this could lead to
- If IVM works better, it could offer PCOS patients a gentler fertility treatment with fewer side effects and less pain.
- What could go wrong
- This is a small, early-stage trial (84 participants) measuring only patient-reported outcomes, not pregnancy success. IVM may not improve comfort or could have unknown drawbacks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PCOS (POLYCYSTIC OVARY SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gut microbiome transplant boost fertility in PCOS?
- A simple blood test may flag hidden insulin problems in PCOS
- Can tracking PCOS over time unlock better care?
- Could two common supplements tame PCOS hormone chaos?
- Sugar test reveals hidden metabolic clues in PCOS
- New PCOS study aims to map hidden patterns of the condition